Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000158450 | SCV000208385 | uncertain significance | not provided | 2022-08-24 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function |
Labcorp Genetics |
RCV001219101 | SCV001391022 | uncertain significance | Hypertrophic cardiomyopathy | 2019-04-05 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with MYBPC3-related conditions. ClinVar contains an entry for this variant (Variation ID: 181131). This variant is present in population databases (rs730880697, ExAC 0.009%). This sequence change replaces threonine with methionine at codon 959 of the MYBPC3 protein (p.Thr959Met). The threonine residue is weakly conserved and there is a moderate physicochemical difference between threonine and methionine. |